Mikel Berdud : Citation Profile


Are you Mikel Berdud?

Office of Health Economics

2

H index

0

i10 index

9

Citations

RESEARCH PRODUCTION:

2

Articles

11

Papers

RESEARCH ACTIVITY:

   6 years (2012 - 2018). See details.
   Cites by year: 1
   Journals where Mikel Berdud has often published
   Relations with other researchers
   Recent citing documents: 8.    Total self citations: 1 (10 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pbe1130
   Updated: 2020-08-01    RAS profile: 2018-12-20    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Towse, Adrian (4)

Hampson, Grace (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Mikel Berdud.

Is cited by:

Lorgelly, Paula (1)

Husereau, Don (1)

Neri, Margherita (1)

Garau, Martina (1)

Cites to:

Tirole, Jean (14)

Jewitt, Ian (10)

Dewatripont, Mathias (10)

Ghatak, Maitreesh (6)

Gromb, Denis (4)

Mueller, Hannes (4)

Hwang, Sung-Ha (3)

Delfgaauw, Josse (3)

Frey, Bruno (3)

Dur, Robert (3)

Jegen, Reto (3)

Main data


Where Mikel Berdud has published?


Working Papers Series with more than one paper published# docs
Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra / Departamento de Economía - Universidad Pública de Navarra6
Research Papers / Office of Health Economics3
Consulting Reports / Office of Health Economics2

Recent works citing Mikel Berdud (2018 and 2017)


YearTitle of citing document
2019Competition between on-patent medicines in Europe. (2019). Wilsdon, Tim ; Roediger, Alexander ; Azais, Boris ; Pendleton, Kathy ; Haderi, Artes. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:7:p:652-660.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084.

Full description at Econpapers || Download paper

2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees ; Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

Full description at Econpapers || Download paper

2018Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching. (2018). Husereau, Don ; Selya-Hammer, Carl ; Feagan, Brian. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:3:d:10.1007_s40258-018-0371-0.

Full description at Econpapers || Download paper

2018Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates. (2018). Espin, Jaime ; Jommi, Claudio ; Parnaby, Adam ; Flostrand, Steven ; Hutchings, Adam ; Borget, Isabelle ; Mestre-Ferrandiz, Jorge ; Anderson, Pippa ; Godman, Brian ; Schlander, Michael. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:6:d:10.1007_s40258-018-0419-1.

Full description at Econpapers || Download paper

2019Is rate of return pricing a useful approach when value-based pricing is not appropriate?. (2019). Towse, Adrian ; Drummond, Michael. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:7:d:10.1007_s10198-019-01032-7.

Full description at Econpapers || Download paper

2017Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis. (2017). Simoens, Steven ; Shane, Lesley G ; Isakov, Leah ; Popovian, Robert ; Jacobs, Ira. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0529-x.

Full description at Econpapers || Download paper

2018The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5.

Full description at Econpapers || Download paper

Works by Mikel Berdud:


YearTitleTypeCited
2012Incentives Beyond the Money and Motivational Capital in Health Care Organizations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2012Motivational Capital and Incentives in Health Care Organisations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2012Incentives Beyond the Money: Identity and Motivational Capital in Public Organizations In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014A Pilot Inquiry on Incentives and Intrinsic Motivation in Health Care: the Motivational Capital Explained by Doctors In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2017Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market In: Consulting Reports.
[Full Text][Citation analysis]
paper1
2018Review of CRAs Report Assessing the Economic Impacts of Changing Exemption Provisions During Patent and SPC Protection in Europe In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2017Macro Evaluation of the NIHR Oxford Biomedical Research Centre In: Research Papers.
[Full Text][Citation analysis]
paper0
2018Establishing a Reasonable Price for an Orphan Drug In: Research Papers.
[Full Text][Citation analysis]
paper1
2018R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Papers.
[Full Text][Citation analysis]
paper2
2016Fostering incentives for research, development, and delivery of interventions for neglected tropical diseases: lessons from malaria In: Oxford Review of Economic Policy.
[Full Text][Citation analysis]
article0
2016Biosimilars: How Can Payers Get Long-Term Savings? In: PharmacoEconomics.
[Full Text][Citation analysis]
article5

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated July, 2 2020. Contact: CitEc Team